Isofol Medical AB (publ) announced that Thomas Andersson, at his own request, has chosen to resign as Chief Executive Officer of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 SEK | +0.14% | -3.45% | -4.11% |
02-20 | Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
02-20 | Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-4.11% | 10.43M | |
+15.09% | 74.45B | |
+11.65% | 9.18B | |
+54.35% | 5.03B | |
-12.85% | 5.02B | |
+1.60% | 3.82B | |
-20.85% | 2.41B | |
+16.88% | 2.39B | |
-29.25% | 2.27B | |
+24.62% | 2.26B |
- Stock Market
- Equities
- ISOFOL Stock
- News Isofol Medical AB
- Isofol Medical AB Announces Resignation of Thomas Andersson as Chief Executive Officer